- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Chronic Spontaneous Urticaria
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Article
New dermal filler launched
San Diego - Artes Medical announces the immediate launch and commercial sale of Food and Drug Administration-approved Elevess, a new hyaluronic acid dermal filler formulated with an anesthetic for patient comfort, according to a press release.
San Diego
- Artes Medical announces the immediate launch and commercial sale of Food and Drug Administration-approved Elevess, a new hyaluronic acid dermal filler formulated with an anesthetic for patient comfort, according to a press release.
Elevess is a safe, effective and less expensive alternative for the treatment of facial wrinkles, particularly nasolabial folds. In a radomized, controlled pivotal study of 208 patients, Elevess was shown to be safe and effective for up to six months, according to the company.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
